Benign prostatic hyperplasia (BPH) with associated lower urinary tract symptoms (LUTS) is a common medical condition in males over 50 years of age and is not usually a serious threat to health. In the United Kingdom the number of men with symptomatic BPH who require a surgical treatment is projected at 25,000 annual incidences.
REZUM is suitable for the majority of men presenting with urinary symptoms due to an enlarged prostate. It is carried out as a day procedure and is an excellent choice for those who wish to retain their sexual function.
The REZUM Therapy system consists of a portable radiofrequency (RF) generator and Delivery Device to heat up a controlled amount of water in the Delivery Device outside of the body, converting the water into vapour or steam which is delivered into the prostate tissue that causes BPH.
RF energy from the generator is applied to an inductive coil in the Delivery Device to create steam and this energy is delivered into the prostate tissue through emitter holes in the Delivery Device needle to ablate (destroy) the targeted obstructive prostate tissue that causes BPH.
During the treatment, saline is delivered through the device to enable visualisation and to keep the urethra cool and protect it from the thermal effects of the vapour during treatments.
• Preservation of sexual function
• Significant improvement in BPH symptoms
• A rapid return to normal daily activities
• Fewer adverse events
• A good alternative to offer patients with an improved quality of life
• Can be carried out under sedation without the need of a general anaesthetic
• A day case procedure
The REZUM Therapy System offers an alternative to standard BPH management and has been supported by The National Institute of Clinical Excellence (NICE).
Prostate Mapping (also known as Transperineal template biopsy) is a diagnostic procedure to find out if a patient has prostate cancer.
Will Quince, Conservative MP for Colchester and former Minister of State for Health recently visited Oaks Hospital in Colchester to see how Ramsay Health Care UK is delivering high quality healthcare for local patients.
On Tuesday 30th August Oaks Hospital hosted the official opening of its brand new SACT (Systemic Anti-Cancer Therapy) unit, which offers oncology services to patients for a range of specialty areas including skin, gynaecology, urology and breast cancers in the local area.
Oaks Hospital is celebrating after being named as a National Joint Registry (NJR) Quality Data Provider after successfully completing a national programme of local data audits.